Literature DB >> 9359650

Hydranencephaly with renal dysgenesis: a coincidental finding? Case report with review of the literature.

A Gschwendtner1, T Mairinger, E Soelder, A Alge, A Kreczy.   

Abstract

We present the case of a female fetus aborted in the 20th week of gestation due to severely dysplastic kidneys, anhydramnios and hydranencephalus. The combination of these malformations is extremely rare, resulting in only 4 cases described so far. Our case is the first ever presented in a female showing polycystic-dysplastic kidneys. Multiple multinucleated neurons were a remarkable finding in the remnants of the brain. The possibility of an underlying genetic disorder is discussed, together with a brief review of the literature to date.

Entities:  

Mesh:

Year:  1997        PMID: 9359650     DOI: 10.1159/000291522

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  An Amish founder variant consolidates disruption of CEP55 as a cause of hydranencephaly and renal dysplasia.

Authors:  Lettie E Rawlins; Hannah Jones; Olivia Wenger; Myat Aye; James Fasham; Gaurav V Harlalka; Barry A Chioza; Alexander Miron; Sian Ellard; Matthew Wakeling; Andrew H Crosby; Emma L Baple
Journal:  Eur J Hum Genet       Date:  2019-01-08       Impact factor: 4.246

Review 2.  Hydranencephaly: cerebral spinal fluid instead of cerebral mantles.

Authors:  Piero Pavone; Andrea D Praticò; Giovanna Vitaliti; Martino Ruggieri; Renata Rizzo; Enrico Parano; Lorenzo Pavone; Giuseppe Pero; Raffaele Falsaperla
Journal:  Ital J Pediatr       Date:  2014-10-18       Impact factor: 2.638

3.  A truncating mutation in CEP55 is the likely cause of MARCH, a novel syndrome affecting neuronal mitosis.

Authors:  Patrick Frosk; Heleen H Arts; Julien Philippe; Carter S Gunn; Emma L Brown; Bernard Chodirker; Louise Simard; Jacek Majewski; Somayyeh Fahiminiya; Chad Russell; Yangfan P Liu; Robert Hegele; Nicholas Katsanis; Conrad Goerz; Marc R Del Bigio; Erica E Davis
Journal:  J Med Genet       Date:  2017-03-06       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.